Candriam SCA’s Qiagen QGEN Stock Holding History

Candriam SCA’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10	Closed	-$1K	–	814
2022 Q1	$1K	Buy	+10	New	+$516	﹤0.01%	802

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Candriam SCA's QGEN Position: Q2 2022 in Review

Candriam SCA sold out of Qiagen (QGEN) in Q2 2022, closing a stake of 10 shares — an estimated $1K sold.

Candriam SCA first reported a position in QGEN in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

Candriam SCA reported no remaining Qiagen position as of Q2 2022 after selling out during the quarter.
Candriam SCA sold 10 Qiagen shares in Q2 2022, an estimated $1K.
Candriam SCA first reported a position in Qiagen in Q1 2022 and held it in 1 quarter.
Candriam SCA's Qiagen position peaked at $1K in Q1 2022.
287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Candriam SCA's 13F filing for Q2 2022, filed 3 Aug 2022.